Jeff Aronin, chairman and CEO of Biomedical Innovator Paragon Biosciences

Paragon Bioscience, led by chairman and CEO Jeff Aronin, is dedicated to improving medicine by supporting innovations in biomedical technologies. Paragon is an incubator and investor in the field of bioscience, which means they help fund and grow bioscience companies that they consider promising or innovative. Paragon currently has a diverse portfolio of cutting-edge biotech companies, including Castle Creek Pharmaceuticals, Harmony Biosciences, and Decade, a company that researches new types of therapy for people with Alzheimer’s.

Paragon’s approach is patient-driven, which means that they start by researching untreated diseases or conditions and then build bioscience companies to help treat these conditions. This business model serves Paragon well, as it guides their rational drug development programs and helps them speed along the approval process for promising and innovative treatments. Currently, Paragon has a pipeline of experimental drugs for the treatment of four different types of conditions, including central nervous system disorders, orphan dermatology, broader dermatology and pre-malignant oral lesions.

Jeff Aronin, the CEO of Paragon since 2010, has many years of experience leading biomedical companies and is an expert in business planning and development and brand marketing. In addition to serving as the CEO for Paragon, Mr. Aronin is also the non-executive chairman of multiple Paragon portfolio companies, including Castle Creek Pharmaceuticals and Harmony Biosciences. He has also served on the Board of Directors for Discover Financial Services since 2007.

Jeff Aronin’s skills and successes have made him one of the most innovative leaders in the bioscience sector, particularly in the field of biomedicine. His teams of scientists and executives have gotten 13 different Novel Drug Approvals from the FDA, which represent potentially life-saving medications for patients suffering from untreated medical conditions. Jeff Aronin also remains active in the field of philanthropy by supporting a variety of non-profit organizations dedicated to improving patient outcomes for different disease states. The non-profits that Mr. Aronin has supported include the Juvenile Diabetes Research Foundation, the JED Foundation for Depression, Liver Life Challenge and the Cystic Fibrosis Foundation, among other organizations.



Leave a Reply

Your email address will not be published. Required fields are marked *